National Research Co. (NASDAQ:NRC) Shares Purchased by Azzad Asset Management Inc. ADV

Azzad Asset Management Inc. ADV raised its holdings in National Research Co. (NASDAQ:NRC) by 35.9% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 25,090 shares of the company’s stock after acquiring an additional 6,629 shares during the period. Azzad Asset Management Inc. ADV owned approximately 0.11% of National Research worth $994,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. increased its position in National Research by 1.1% during the third quarter. Vanguard Group Inc. now owns 980,693 shares of the company’s stock worth $43,513,000 after purchasing an additional 10,454 shares during the last quarter. Conestoga Capital Advisors LLC increased its holdings in shares of National Research by 1.0% during the 4th quarter. Conestoga Capital Advisors LLC now owns 780,806 shares of the company’s stock worth $30,889,000 after buying an additional 7,591 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of National Research by 1.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 636,402 shares of the company’s stock worth $25,176,000 after buying an additional 7,531 shares during the last quarter. iA Global Asset Management Inc. purchased a new stake in shares of National Research during the 3rd quarter valued at approximately $11,124,000. Finally, Comerica Bank purchased a new position in National Research in the third quarter worth approximately $6,939,000. 47.26% of the stock is owned by hedge funds and other institutional investors.

National Research Trading Up 0.3 %

NRC stock traded up $0.06 during mid-day trading on Wednesday, hitting $22.95. 23,686 shares of the company were exchanged, compared to its average volume of 85,338. National Research Co. has a 12-month low of $22.47 and a 12-month high of $47.25. The firm has a market capitalization of $548.05 million, a P/E ratio of 18.46 and a beta of 0.50. The business has a fifty day simple moving average of $28.84 and a 200-day simple moving average of $35.28. The company has a quick ratio of 0.41, a current ratio of 0.41 and a debt-to-equity ratio of 0.75.

National Research (NASDAQ:NRC) last released its quarterly earnings results on Tuesday, May 7th. The company reported $0.27 EPS for the quarter. The business had revenue of $35.31 million during the quarter. National Research had a return on equity of 54.83% and a net margin of 20.60%.

National Research Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, July 15th. Shareholders of record on Friday, June 28th will be given a $0.12 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $0.48 annualized dividend and a yield of 2.09%. National Research’s dividend payout ratio is presently 38.71%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.